Why Your Body Destroys NAD+ Before It Can Use It (And the $5 Fix Nobody Talks About)

Your body cannot use NAD+ directly. The molecule is too large to cross a cell membrane, so when you swallow an NAD+ supplement or receive it through an IV, your body breaks it apart outside the cell, transports the pieces through the membrane, and then rebuilds NAD+ on the inside. That reassembly process is called the salvage pathway, and it is the only route that NMN and NR supplements use to raise your cellular NAD+ levels.

That matters more than most people realize, because the salvage pathway is not running at full capacity.

There is an enzyme called CD38, which is essentially a NAD+ shredder, and its activity increases two to three fold as you age across multiple tissue types. The research on this shows a near-perfect inverse correlation between CD38 activity and NAD+ levels, meaning as CD38 goes up, NAD+ comes down almost in lockstep. So every precursor you take, whether it is NMN or NR, is funneling into a pathway that is increasingly overwhelmed with age.

NMN adds another step on top of that. Before NMN can even enter a cell, an enzyme called CD73 has to convert it into NR first, which means NMN and NR are not really competing products. They are the same molecule by the time they reach the cell membrane. Both become NR, both enter through the salvage pathway, and both face the same CD38 problem on the other side.

This is also why IV NAD+ does not solve the problem the way people think it does. A 2019 study tracked what happens during a 750 milligram intravenous NAD+ infusion over six hours. The NAD+ was rapidly and completely cleared from plasma before it ever reached cells. The metabolite profile confirmed it was being degraded extracellularly, broken down into pieces that then had to be transported and reassembled through the same salvage pathway. The IV route bypasses your gut, but it does not bypass the biology.

Now here is where the pathway map becomes useful, because the salvage pathway is not the only road into the cell.

Your body has a second synthesis route called the Preiss-Handler pathway, which uses plain niacin, also known as vitamin B3, as its starting material. The Preiss-Handler pathway is structurally separate from the salvage pathway. It does not compete for the same enzymes, it does not go through CD73, and CD38 does not intercept it at the same point. It is a different on-ramp to the same destination.

A 2020 study tested this in a population with confirmed NAD+ deficiency, specifically adults with mitochondrial myopathy where the NAD+ deficit was measurable and documented. Participants took niacin at doses between 750 and 1000 milligrams per day. After the intervention, blood NAD+ levels were 2.3 times higher than baseline, and muscle NAD+ levels were 1.3 times higher. Those participants also showed improvements in muscle strength and markers of mitochondrial biogenesis, meaning the NAD+ increase was functional, not just a number on a lab test.

A 2.3 fold increase in blood NAD+ puts niacin in the same range as what the premium NMN and NR products are marketed to produce, at a fraction of the cost.

There is a catch worth knowing about. Niacin causes something called a flush, which is a temporary reddening of the skin, usually on the face, chest, and arms, sometimes accompanied by a warming or itching sensation. This happens because niacin activates prostaglandin receptors in the skin. It is not a sign of harm, it is not an allergic reaction, and it typically fades after the first one to two weeks of consistent use as your receptors downregulate. Starting at a lower dose and taking niacin with food reduces the intensity of it in the early days.

There is also a form called nicotinamide, which does not cause a flush, but the evidence on nicotinamide specifically raising NAD+ via the Preiss-Handler pathway at clinical doses is not as clean as the niacin literature, so that substitution is not straightforward.

One more detail that the research surfaced and that most people discussing NR supplementation have not absorbed: a 2019 study on NR in aged human skeletal muscle found that NR supplementation produced significant increases in NAAD, which is an intermediate in the Preiss-Handler pathway. That finding suggests NR is not staying purely in the salvage pathway once it is inside the body. Some fraction of it is being converted to nicotinic acid and entering the Preiss-Handler pathway anyway. So the two pathways are not perfectly isolated in practice, but the Preiss-Handler pathway is what niacin was built for, and niacin hits it directly.

The practical takeaway is straightforward. If you are taking NMN or NR to raise NAD+ levels and you are not seeing the effect you expected, or you are looking for a lower cost option that uses a different biological mechanism, niacin at 750 to 1000 milligrams per day is supported by human trial data in a population with actual NAD+ deficiency. It costs roughly five dollars a month at any pharmacy. The flush is real but temporary.

The deeper point is this: the expensive supplements are not wrong about the biology, they are just using the congested road when there is an open one right next to it.

---

References

1. Ratajczak J, Joffraud M, Trammell SAJ, et al. 2016. NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells. Nature Communications, 7:13103. Finding: NMN must be converted to NR by CD73 before cellular uptake, establishing NR as the common entry point for both NMN and NR supplementation. Source
2. Elhassan YS, Kluckova K, Fletcher RS, et al. 2019. Nicotinamide riboside augments the aged human skeletal muscle NAD+ metabolome and induces transcriptomic and anti-inflammatory signatures. Cell Reports, 287:1717-1728. Finding: NR supplementation produced significant increases in NAAD a Preiss-Handler pathway intermediate in human muscle, indicating NR partially converts to nicotinic acid in vivo. Source
3. Pirinen E, Auranen M, Khan NA, et al. 2020. Niacin cures systemic NAD+ deficiency and improves muscle performance in adult-onset mitochondrial myopathy. Cell Metabolism, 316:1078-1090. Finding: Niacin 750-1000 mg/day raised blood NAD+ 2.3x and muscle NAD+ 1.3x in human subjects via the Preiss-Handler pathway, with concurrent improvements in muscle strength and mitochondrial biogenesis. Source
4. Grant R, Berg J, Mestayer R, et al. 2019. A pilot study investigating changes in the human plasma and urine NAD+ metabolome during a 6 hour intravenous infusion of NAD+. Frontiers in Aging Neuroscience, 11:257. Finding: IV NAD+ 750 mg was rapidly and completely removed from plasma, with metabolites confirming full extracellular degradation before cellular uptake. Source
5. Camacho-Pereira J, Tarrago MG, Chini CCS, et al. 2016. CD38 dictates age-related NAD decline and mitochondrial dysfunction through an SIRT3-dependent mechanism. Cell Metabolism, 236:1127-1139. Finding: CD38 activity increases 2-3 fold with age across tissues, with near-perfect inverse correlation to NAD+ levels. Source

---

Join the free community:
Men: Iron Forge Brotherhood
Women: Powerhouse Fitness